- Cloud-native software company SOPHiA GENETICS (NASDAQ:SOPH) partnered with Strand Life Sciences, a bioinformatics and diagnostics provider, to deliver innovative solutions that will fuel the use of precision medicine globally.
- The new collaboration will leverage the industry-leading strengths from both companies to provide access to advanced genomics technologies, cutting-edge bioinformatics services and innovative diagnostics solutions.
- The two companies will use their bioinformatics expertise to expand the ability to accurately analyze key healthcare data and facilitate the use of data-driven decision-making globally.
